Using this model, Malehmir et al. demonstrated that platelet recruitment to the liver contributes to the development of nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) via platelet glycoprotein Ibα (GPIbα) [92]. This evidence concerns the gene GP1BA and metabolic dysfunction-associated steatohepatitis.